Carl Zeiss Meditec AG (AFX.DE)
EUR 59.8
(-0.5%)
EUR 59.8
(-0.5%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 133.88 Million EUR | 25.93% |
| 2022 | 106.31 Million EUR | 4.3% |
| 2021 | 101.92 Million EUR | 91.98% |
| 2020 | 53.09 Million EUR | 23.97% |
| 2019 | 42.82 Million EUR | 485.0% |
| 2018 | 7.32 Million EUR | 144.44% |
| 2017 | 2.99 Million EUR | -51.11% |
| 2016 | 6.12 Million EUR | -31.39% |
| 2015 | 8.92 Million EUR | -14.27% |
| 2014 | 10.41 Million EUR | -12.98% |
| 2013 | 11.96 Million EUR | -28.55% |
| 2012 | 16.75 Million EUR | 92.29% |
| 2011 | 8.71 Million EUR | -47.77% |
| 2010 | 16.68 Million EUR | -1.33% |
| 2009 | 16.9 Million EUR | -8.85% |
| 2008 | 18.54 Million EUR | -43.42% |
| 2007 | 32.77 Million EUR | 0.0% |
| 2006 | - EUR | 0.0% |
| 2005 | - EUR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - EUR | 0.0% |
| 2024 Q2 | 120.16 Million EUR | 0.0% |
| 2024 Q3 | - EUR | 0.0% |
| 2023 Q3 | - EUR | -100.0% |
| 2023 Q1 | - EUR | -100.0% |
| 2023 Q2 | 134.52 Million EUR | 0.0% |
| 2023 Q4 | 133.88 Million EUR | 0.0% |
| 2023 FY | 133.88 Million EUR | 25.93% |
| 2022 FY | 106.31 Million EUR | 4.3% |
| 2022 Q4 | 106.31 Million EUR | 0.0% |
| 2022 Q3 | - EUR | -100.0% |
| 2022 Q2 | 101.07 Million EUR | 0.0% |
| 2022 Q1 | - EUR | -100.0% |
| 2021 FY | 101.92 Million EUR | 91.98% |
| 2021 Q2 | 102.02 Million EUR | 0.0% |
| 2021 Q3 | - EUR | -100.0% |
| 2021 Q4 | 101.92 Million EUR | 0.0% |
| 2021 Q1 | - EUR | -100.0% |
| 2020 Q4 | 53.09 Million EUR | 0.0% |
| 2020 Q3 | - EUR | -100.0% |
| 2020 FY | 53.09 Million EUR | 23.97% |
| 2020 Q1 | - EUR | -100.0% |
| 2020 Q2 | 38.22 Million EUR | 0.0% |
| 2019 Q3 | - EUR | -100.0% |
| 2019 Q4 | 42.82 Million EUR | 0.0% |
| 2019 Q1 | - EUR | -100.0% |
| 2019 FY | 42.82 Million EUR | 485.0% |
| 2019 Q2 | 51.37 Million EUR | 0.0% |
| 2018 Q1 | - EUR | -100.0% |
| 2018 Q3 | - EUR | -100.0% |
| 2018 Q4 | 7.32 Million EUR | 0.0% |
| 2018 FY | 7.32 Million EUR | 144.44% |
| 2018 Q2 | 1.44 Million EUR | 0.0% |
| 2017 Q2 | 4.84 Million EUR | 0.0% |
| 2017 Q3 | - EUR | -100.0% |
| 2017 FY | 2.99 Million EUR | -51.11% |
| 2017 Q1 | - EUR | -100.0% |
| 2017 Q4 | 2.99 Million EUR | 0.0% |
| 2016 Q2 | 7.59 Million EUR | -10.03% |
| 2016 FY | 6.12 Million EUR | -31.39% |
| 2016 Q1 | 8.44 Million EUR | -5.45% |
| 2016 Q4 | 6.12 Million EUR | -13.49% |
| 2016 Q3 | 7.08 Million EUR | -6.77% |
| 2015 Q2 | 10.7 Million EUR | 5.36% |
| 2015 Q4 | 8.92 Million EUR | -7.37% |
| 2015 FY | 8.92 Million EUR | -14.27% |
| 2015 Q3 | 9.63 Million EUR | -9.96% |
| 2015 Q1 | 10.16 Million EUR | -2.45% |
| 2014 Q2 | 10.63 Million EUR | -5.08% |
| 2014 Q4 | 10.41 Million EUR | 2.16% |
| 2014 FY | 10.41 Million EUR | -12.98% |
| 2014 Q1 | 11.2 Million EUR | -6.42% |
| 2014 Q3 | 10.19 Million EUR | -4.1% |
| 2013 Q3 | 12.8 Million EUR | -5.34% |
| 2013 Q4 | 11.96 Million EUR | -6.56% |
| 2013 FY | 11.96 Million EUR | -28.55% |
| 2013 Q1 | 13.64 Million EUR | -18.57% |
| 2013 Q2 | 13.53 Million EUR | -0.8% |
| 2012 Q4 | 16.75 Million EUR | 10.72% |
| 2012 Q2 | 14.75 Million EUR | -5.41% |
| 2012 Q3 | 15.13 Million EUR | 2.54% |
| 2012 FY | 16.75 Million EUR | 92.29% |
| 2012 Q1 | 15.59 Million EUR | 79.05% |
| 2011 Q1 | 16.65 Million EUR | -0.17% |
| 2011 FY | 8.71 Million EUR | -47.77% |
| 2011 Q4 | 8.71 Million EUR | -40.96% |
| 2011 Q3 | 14.75 Million EUR | -5.42% |
| 2011 Q2 | 15.6 Million EUR | -6.31% |
| 2010 Q4 | 16.68 Million EUR | -11.64% |
| 2010 FY | 16.68 Million EUR | -1.33% |
| 2010 Q3 | 18.87 Million EUR | 7.32% |
| 2010 Q1 | 16.88 Million EUR | -0.13% |
| 2010 Q2 | 17.59 Million EUR | 4.19% |
| 2009 FY | 16.9 Million EUR | -8.85% |
| 2009 Q4 | 16.9 Million EUR | 0.0% |
| 2008 FY | 18.54 Million EUR | -43.42% |
| 2007 FY | 32.77 Million EUR | 0.0% |
| 2006 FY | - EUR | 0.0% |
| 2005 FY | - EUR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| SCHOTT Pharma AG & Co. KGaA | 69.19 Million EUR | -93.488% |
| Fielmann Aktiengesellschaft | 6.95 Million EUR | -1824.946% |
| Gerresheimer AG | 658.49 Million EUR | 79.669% |
| Sartorius Aktiengesellschaft | 5.02 Billion EUR | 97.335% |
| Sartorius Aktiengesellschaft | 5.02 Billion EUR | 97.335% |